On Dec. 10, 2021, the World Health Organization announced interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine.

The WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine (updated on 9 December) were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization.